Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 2
2000 3
2001 2
2002 1
2003 1
2004 3
2005 4
2006 1
2007 3
2008 3
2009 5
2010 4
2011 7
2012 6
2013 5
2014 4
2015 3
2016 12
2017 9
2018 7
2019 8
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.
Spear TT, Evavold BD, Baker BM, Nishimura MI. Spear TT, et al. Among authors: baker bm. Cancer Immunol Immunother. 2019 Nov;68(11):1881-1889. doi: 10.1007/s00262-019-02401-0. Epub 2019 Oct 8. Cancer Immunol Immunother. 2019. PMID: 31595324 Review.
Structure Based Prediction of Neoantigen Immunogenicity.
Riley TP, Keller GLJ, Smith AR, Davancaze LM, Arbuiso AG, Devlin JR, Baker BM. Riley TP, et al. Among authors: baker bm. Front Immunol. 2019 Aug 28;10:2047. doi: 10.3389/fimmu.2019.02047. eCollection 2019. Front Immunol. 2019. PMID: 31555277 Free PMC article.
LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain.
McGrath E, Waschbüsch D, Baker BM, Khan AR. McGrath E, et al. Among authors: baker bm. Small GTPases. 2019 Sep 25:1-14. doi: 10.1080/21541248.2019.1666623. Online ahead of print. Small GTPases. 2019. PMID: 31552791
LRRK2 is a multi-domain Ser/Thr kinase that is associated with inherited and sporadic cases of Parkinson's disease. Many mutations linked to disease are associated within a central ROC-COR regulatory region and the subsequent kinase domain, leading to enhanced catalytic ac …
LRRK2 is a multi-domain Ser/Thr kinase that is associated with inherited and sporadic cases of Parkinson's disease. Many mutations li …
T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.
Riley TP, Hellman LM, Gee MH, Mendoza JL, Alonso JA, Foley KC, Nishimura MI, Vander Kooi CW, Garcia KC, Baker BM. Riley TP, et al. Among authors: baker bm. Nat Chem Biol. 2018 Oct;14(10):934-942. doi: 10.1038/s41589-018-0130-4. Epub 2018 Sep 17. Nat Chem Biol. 2018. PMID: 30224695 Free PMC article.
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, Dellacecca E, Garrett-Mayer E, Li M, Eby JM, Stiff PJ, Evavold BD, Baker BM, Le Poole IC, Dropulic B, Clark JI, Nishimura MI. Moore T, et al. Among authors: baker bm. Cancer Immunol Immunother. 2018 Feb;67(2):311-325. doi: 10.1007/s00262-017-2073-0. Epub 2017 Oct 20. Cancer Immunol Immunother. 2018. PMID: 29052782 Free PMC article.
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
Ebrahimi-Nik H, Michaux J, Corwin WL, Keller GL, Shcheglova T, Pak H, Coukos G, Baker BM, Mandoiu II, Bassani-Sternberg M, Srivastava PK. Ebrahimi-Nik H, et al. Among authors: baker bm. JCI Insight. 2019 Jun 20;5(14):e129152. doi: 10.1172/jci.insight.129152. JCI Insight. 2019. PMID: 31219806 Free PMC article.
The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics.
Riley TP, Baker BM. Riley TP, et al. Among authors: baker bm. Semin Cell Dev Biol. 2018 Dec;84:30-41. doi: 10.1016/j.semcdb.2017.10.017. Semin Cell Dev Biol. 2018. PMID: 30449534 Review.
Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.
Singh NK, Abualrous ET, Ayres CM, Noé F, Gowthaman R, Pierce BG, Baker BM. Singh NK, et al. Among authors: baker bm. Proteins. 2020 Mar;88(3):503-513. doi: 10.1002/prot.25829. Epub 2019 Oct 21. Proteins. 2020. PMID: 31589793
Traditionally, TCR binding geometry has been described with simple descriptors such as the crossing angle, which quantifies what has become known as the TCR's diagonal binding mode. ...
Traditionally, TCR binding geometry has been described with simple descriptors such as the crossing angle, which quantifies what has become …
Peptide and Peptide-Dependent Motions in MHC Proteins: Immunological Implications and Biophysical Underpinnings.
Ayres CM, Corcelli SA, Baker BM. Ayres CM, et al. Among authors: baker bm. Front Immunol. 2017 Aug 7;8:935. doi: 10.3389/fimmu.2017.00935. eCollection 2017. Front Immunol. 2017. PMID: 28824655 Free PMC article. Review.
Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.
Singh NK, Riley TP, Baker SCB, Borrman T, Weng Z, Baker BM. Singh NK, et al. Among authors: baker bm. J Immunol. 2017 Oct 1;199(7):2203-2213. doi: 10.4049/jimmunol.1700744. J Immunol. 2017. PMID: 28923982 Free PMC article. Review.
92 results
Jump to page
Feedback